Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14)
Market Open
7 Aug, 09:00
SGX 
SSE Primary SGX $
2. 75
+0.01
+0.365%
$
- Market Cap
- P/E Ratio
0.6% Div Yield
170,700 Volume
- Eps
$ 2.74
Previous Close Want to track T14 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14) Statistics
Valuation metrics
Market Cap -
Enterprise value 20.35B
Trailing P/E (ttm) 13.13
Forward P/E -
PEG ratio -7.56
Price/Sales (ttm) 4.26
Price/Book (mrq) 3.81
Enterprise Value/Revenue 4.09
Enterprise Value/EBITDA 18.96
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 203.29K
Average volume (90 days) 207.03K
Price summary
52-Week low 2.48
52-Week high 3.75
Beta -
50-Day moving average 2.82
200-Day moving average 3.15
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.34
Trailing annual dividend yield 0.0629%
5-Year annual dividend yield -
Payout ratio 0.86
Dividend Date 10 Jul 2026
Ex-Dividend Date 29 Jun 2026
Last split factor 2:1
Last split Date 30 Jun 2010
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.44%
Operating margin 0.49%
Operational effectiveness
Return on assets 0.21%
Return on equity 0.27%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 6.46
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.3
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 2.16%
Book value per share (mrq) 9.77
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
